title: Does interruption of normothermic cardioplegia have adverse effects on myocardium? A retrospective and prospective clinical evaluation.
abstract: A total of 154 patients who underwent isolated coronary revascularization (coronary artery bypass grafting) using retrograde, near-continuous, warm cardioplegia for myocardial protection, were arbitrarily divided into three groups according to the cumulative cardioplegic interruption (i.e. the sum total of all the short cardioplegic interruption periods, expressed as a percentage of the cardiac arrest period). Group 1 (39 patients) had < 20% interruption (mean(s.e.m.) 12.5(0.01)%), group 2 (82 patients) had 20-39% interruption (mean(s.e.m.) 30.1(0.01)%) and group 3 (33 patients) had > 40% interruption (mean(s.e.m.) 45.4(0.01%). The three groups were comparable except for longer clamp time in group 3 and a lower cardiac index in group 1. The mean number and duration of cardioplegic interruptions and reperfusions and multiple clinical outcomes were recorded. Clinical outcomes (Q) wave perioperative infraction, use of an intra-aortic balloon pump, mortality, and length of stay in the intensive care unit and hospital) were the same in all groups despite significant differences in percent, number and duration of interruption and reperfusion as well as cardiac arrest. The only significant differences found were in the level of creatine kinase-MB (CK-MB) and use of inotropes after surgery, both being higher in group 1 than in groups 2 and 3 (which is the opposite of what would be expected). Intraoperative hemodynamic (cardiac index and left ventricular ejection fraction) and metabolic evaluations (CK-MB, lactate production and oxygen extraction) in 22 additional patients who underwent coronary artery bypass grafting showed no significant differences between two groups having < 30% versus > 30% cumulative cardioplegic interruption. It is concluded that warm cardioplegic interruption as used clinically has no adverse effects on the myocardium in patients undergoing coronary revascularization. Warm retrograde near-continuous blood cardioplegia is an effective method of myocardial protection.
authors: Division of Cardiac Surgery, Springfield, MA 01107, USA.
authors: J A
authors: JA
authors: Rousou
authors: R M
authors: RM
authors: Engelman
authors: J E
authors: JE
authors: Flack
authors: D W
authors: DW
authors: Deaton
authors: R
authors: R
authors: Rifkin
authors: A
authors: A
authors: Elmansoury
mesh_terms: D000368:Aged; D001831:Body Temperature; D001026:Coronary Artery Bypass / Q000379:methods; D005260:Female; D006321:Heart / Q000503:physiopathology*; D006324:Heart Arrest, Induced / Q000009:adverse effects* / Q000379:methods; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D016343:Monitoring, Intraoperative; D009206:Myocardium / Q000378:metabolism*; D011446:Prospective Studies; D012189:Retrospective Studies